Detalhe da pesquisa
1.
Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.
Proc Natl Acad Sci U S A
; 116(33): 16541-16550, 2019 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346082
2.
Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma.
Cancer
; 127(21): 3991-3997, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289094
3.
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Eur J Haematol
; 107(3): 301-310, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973276
4.
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
Am J Hematol
; 96(11): 1374-1384, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324220
5.
Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia.
J Oncol Pharm Pract
; 27(5): 1265-1269, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106104
6.
Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.
Ann Pharmacother
; 54(4): 371-379, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648540
7.
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.
Acta Haematol
; 143(1): 40-50, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31315113
8.
Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
Cancer
; 125(7): 1101-1112, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548238
9.
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Cancer
; 125(9): 1507-1517, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694529
10.
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.
Invest New Drugs
; 37(2): 297-306, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132271
11.
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
Cancer
; 124(11): 2306-2315, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579328
12.
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103.
Blood
; 128(21): 2510-2516, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27697771
13.
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
Cancer
; 123(7): 1174-1183, 2017 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27911989
14.
Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type.
Br J Haematol
; 196(4): e30-e33, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642938
15.
A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma.
Br J Haematol
; 175(2): 281-289, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27448091
16.
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.
Am J Hematol
; 91(4): 395-9, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26800311
17.
Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction.
Br J Haematol
; 186(4): e65-e67, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30924125
18.
Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma.
Blood
; 130(11): 1375-1377, 2017 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28733323
19.
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.
Lancet Oncol
; 14(13): 1348-56, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24239220
20.
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles".
ACS Cent Sci
; 10(5): 1115-1116, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38799665